
一 | CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。 白色汽车冲上巴士站。

二 | (视频截图:Facebook/Singapore roads accident.com新加坡公路意外网页)一辆白色汽车失控撞向道路中间的绿色栏杆,静止不动一阵子后,车子突然又再猛冲向前,车头和半个车身冲进了巴士站,冲击力导致保险杠都脱落。男司机随后在清醒的状态下被送入院。一名网民在社媒Facebook的“My Home in Simei Facebook”群组上载一段视频,指他周一(26日)下午4点30分在四美路的慈光学校(Metta School)外面,看见一辆白色汽车撞上道路中间的绿色栏杆。视频可见,白色汽车撞上分隔栏后静止不动,车头盖损坏,部分零件都掉在地上。网民说,随后他在5点20分再次路过该处时,发现白色汽车已撞上学校外面的巴士站,汽车半身卡在巴士站。白色汽车先撞上道路分隔栏,随后又撞上巴士站。(视频截图:Facebook/Adrian Tham)另外一段视频则显示,民防部队和新加坡警察部队人员到现场救援,众人合力将司机从车内移出,让他躺在担架上准备送去医院。

三 | 其他民防部队人员也忙着收拾掉落在分隔栏上的保险杠和零件。绿色栏杆上也被撞破了一个洞。民防部队人员也忙着收拾掉落在分隔栏上的保险杠和零件。(视频截图:Facebook/SG Cars)民防部队和警察部队答复《8视界新闻网》指出,这起交通意外是周一下午4点35分,在四美路往樟宜路上段发生。警察部队透露,53岁的男性司机神智清醒,被送往樟宜综合医院接受治疗。

四 | 警方也正在调查事发肇因。
Current article:http://er8gyvv.chengjuecannaobianmouqueduoyu.shop/news/20260826_6912546.html
Published on:05:09:13
新闻热点
新闻爆料
图片精选
点击排行